|

Alpha-Linolenic Acid (2.6 g/day) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Flaxseed Oil, ALA

Pipeline

Phase 2: 1

Top Sponsors

  • Michal Schnaider Beeri, Ph.D.1

Indications

  • Brain Aging1
  • Apolipoprotein E, Deficiency or Defect of1
  • Blood Brain Barrier1
  • Alzheimer's Disease1
  • Fatty Acids, Omega-31

New Brunswick, New Jersey1 trial

ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults

Rutgers - Institute for Health

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.